ResearchGlucagon-Like Peptide-1 Receptor Agonists and Risk of Systemic and Ocular Vascular Complications in Patients With Type 2 Diabetes and Diabetic Retinopathy
ResearchCardiotoxicity and Peri-Operative Considerations in Immune Checkpoint Inhibitor and Chimeric Antigen Receptor T-Cell Therapy: A Narrative Review
ResearchReply: Balancing Promise and Evidence: Critical Perspectives on SGLT2 Inhibitors for Cardiotoxicity Prevention
ResearchImpact of Marine Microplastics on Neurologic and Functional Disabilities: A Population-Level Study
ResearchAn Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor Agonists
Jun 18, 2025Journal ArticleMarine Microplastic Levels and the Prevalence of Cardiometabolic Diseases in US Coastline Counties.Written by 2 Roon authors & 13 others Via The American Heart Association Journals
ResearchCardiotoxicity of Combined Pegylated Liposomal Doxorubicin and Bevacizumab Therapy: A Propensity-Matched Cohort Study and Disproportionality Analysis
ResearchGLP-1 Receptor Agonists and Sight-Threatening Ophthalmic Complications in Patients With Type 2 Diabetes
ResearchEnvironmental Justice Index and Prevalence of Asthma and COPD in US Neighborhoods: A Population-Based Study
ResearchRising Burden of Hypertensive Heart Disease Mortality Among Young Adults in the United States, 1999 to 2024
Mar 27, 2024Journal ArticleAssociation of Environmental Injustice and Cardiovascular Diseases and Risk Factors in the United States.Written by 1 Roon author & 11 others Via The American Heart Association Journals
ResearchPercutaneous Coronary Intervention Before Transcatheter Aortic Valve Implantation: A Propensity Score Matched Analysis